Study of Immune Responses in Patients With Metastatic Melanoma

Summary

In this study, anti-OX40 will be given to patients with melanoma to find out how the immune system responds to treatment with anti-OX40. It is hoped that this treatment will cause an immune response against melanoma resulting in tumor regression, but this is not known at this time. Anti-OX40 is a large protein that can help immune cells that fight bacteria, viruses and cancer cells.

Timeline

Start

2012-09

Primary completion

2012-09

Completion

2012-09

Drugs

Indications